Business
Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company's management will participate in the following investor conferences in September 2025. Citi's
About this update from Ascentage Pharma Group International
[{"type":"image","alt":"ASCENTAGE PHARMA GROUP INTERNATIONAL","displaySize":"","headline":null,"caption":"ASCENTAGE PHARMA GROUP INTERNATIONAL","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":113,"url":"https://media.zenfs.com/en/globenewswire.com/08e2ffb35cd6ca4b1993dc7253b2f226"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_IJsL001nxkbUKUGjfvIgQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/08e2ffb35cd6ca4b1993dc7253b2f226","width":300,"height":113}},"lazy":false},{"type":"text","content":"ROCKVILLE, Md. and SUZHOU, China, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company's management will participate in the following investor conferences in September 2025.","length":496,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Citi's 2025 Biopharma Back to School: Fireside chat at 4:00 pm EDT on September 3","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"Cantor Global Healthcare Conference 2025: Fireside chat at 2:45 pm EDT on September 4","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"H.C. Wainwright 27th Annual Global Investment Conference: Presentation at 1:30 pm EDT on September 10","length":101,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":271,"olType":false},{"type":"text","content":"The live webcast of the Citi and Cantor events can be accessed from the investors section of the Company’s website at https://ir.ascentage.com/news-events/events. An archived replay will be available for 30 days following the event.","length":232,"tagName":"p"},{"type":"text","content":"About Ascentage Pharma Group International","length":42,"tagName":"p"},{"type":"text","content":"Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”) is a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer. The co...